Three Popular Longevity Drugs Fail Under Scrutiny While Four Alternatives Show Promise
The third compound he discontinued was resveratrol
Biohacker and longevity expert Dave Asprey revealed on his podcast that three widely promoted anti-aging supplements lack solid evidence, while four repurposed drugs demonstrate stronger scientific backing for extending healthspan. His assessment comes after reviewing clinical data and mechanistic studies on compounds commonly used in the biohacking community. Asprey explained that metformin, despite its popularity for longevity, shows inconsistent results in non-diabetic individuals and may interfere with exercise benefits by blocking mitochondrial adaptations. He also quit taking NAD+ precursors like nicotinamide riboside due to poor bioavailability and limited proof of increased cellular NAD+ levels in humans.
The third compound he discontinued was resveratrol, citing failed human trials to replicate the lifespan extensions seen in yeast and mice, along with concerns about its estrogenic activity. Why Metformin May Not Be the Longevity Miracle Many Claim While metformin activates AMPK and mimics some effects of calorie restriction, Asprey noted that long-term use in healthy people could impair muscle growth and insulin sensitivity gains from training. He referenced studies where diabetic patients on metformin lived longer than non-diabetics not on the drug, but argued this reflects disease management rather than direct anti-aging effects in healthy populations.
The drug’s gastrointestinal side effects and vitamin B12 depletion further reduce its appeal for preventive use
The drug’s gastrointestinal side effects and vitamin B12 depletion further reduce its appeal for preventive use. What Are the Four Repurposed Drugs Worth Considering Instead? Asprey shifted focus to four compounds with stronger human data: rapamycin for mTOR inhibition and immune rejuvenation, low-dose naltrexone for modulating inflammation and microglial activity, kanna as a natural SERT inhibitor for mood and stress resilience, and spermidine for inducing autophagy through dietary sources like wheat germ. He emphasized that these agents target core hallmarks of aging with clearer mechanistic rationale and emerging clinical support. How Should Individuals Approach Longevity Supplementation? Rather than chasing single molecules, Asprey advocated for personalized strategies based on biomarkers, genetic predispositions, and lifestyle factors. He stressed that foundational habits—sleep quality, nutrient-dense diet, regular movement, and stress management—remain more impactful than any supplement stack.
The future of longevity medicine, he said, lies in combining intermittent dosing of repurposed drugs with continuous monitoring of epigenetic clocks and inflammatory markers. Frequently Asked Questions Is metformin completely useless for longevity? No, but its benefits appear most pronounced in people with type 2 diabetes or insulin resistance; healthy individuals may experience minimal gains and potential downsides like reduced exercise adaptation. Can rapamycin be used safely for anti-aging? Low-dose intermittent rapamycin shows promise in immune function and cancer prevention, but long-term use requires monitoring for side effects such as mouth ulcers, lipid changes, and increased infection risk. Why did Asprey choose kanna over other mood supplements? Kanna (Sceletium tortuosum) has demonstrated serotonin reuptake inhibition and PDE4 inhibition in studies, offering dual action for anxiety and cognitive flexibility without the dependency risks of pharmaceutical alternatives.